XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Acquisition and Equity-Method Investment - Schedule of Equity-Method Investment (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jul. 02, 2023
Apr. 02, 2023
Jun. 30, 2024
Mar. 31, 2024
Jul. 02, 2023
Mar. 31, 2023
Schedule of Equity Method Investments [Line Items]                
Net sales $ 13,283   $ 13,007   $ 28,162   $ 31,492  
Income from continuing operations 31   2,340   3,159   7,895  
Net income/(loss) 48   2,338   3,171   7,894  
Income attributable to shareholders $ 41   $ 2,327   $ 3,156   $ 7,870  
Haleon [Member]                
Schedule of Equity Method Investments [Line Items]                
Net sales   $ 3,699       $ 7,133    
Cost of sales   (1,370)       (2,966)    
Gross profit   2,329       4,167    
Income from continuing operations   559       618    
Net income/(loss)   559       618    
Income attributable to shareholders   $ 536       $ 583    
Haleon / Consumer Healthcare JV [Member]                
Schedule of Equity Method Investments [Line Items]                
Net sales       $ 3,627       $ 6,889
Cost of sales       (1,392)       (2,888)
Gross profit       2,235       4,001
Income from continuing operations       504       730
Net income/(loss)       504       730
Income attributable to shareholders       $ 473       $ 684